Respiratory Syncytial Virus whole-genome sequencing identifies convergent evolution of sequence duplication in the C-terminus of the G gene

被引:0
作者
Seth A. Schobel
Karla M. Stucker
Martin L. Moore
Larry J. Anderson
Emma K. Larkin
Jyoti Shankar
Jayati Bera
Vinita Puri
Meghan H. Shilts
Christian Rosas-Salazar
Rebecca A. Halpin
Nadia Fedorova
Susmita Shrivastava
Timothy B. Stockwell
R. Stokes Peebles
Tina V. Hartert
Suman R. Das
机构
[1] Infectious Diseases Group,Division of Infectious Diseases, Department of Pediatrics
[2] J. Craig Venter Institute,Department of Medicine
[3] Bioinformatics Group,Division of Allergy, Department of Medicine
[4] J. Craig Venter Institute,Division of Allergy, Department of Pediatrics
[5] Center for Bioinformatics and Computational Biology,undefined
[6] University of Maryland,undefined
[7] Emory University School of Medicine and Children’s Healthcare of Atlanta,undefined
[8] Vanderbilt University School of Medicine,undefined
[9] Pulmonary,undefined
[10] and Critical Care Medicine,undefined
[11] Vanderbilt University School of Medicine,undefined
[12] Immunology,undefined
[13] and Pulmonary Medicine,undefined
[14] Vanderbilt University School of Medicine,undefined
来源
Scientific Reports | / 6卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Respiratory Syncytial Virus (RSV) is responsible for considerable morbidity and mortality worldwide and is the most important respiratory viral pathogen in infants. Extensive sequence variability within and between RSV group A and B viruses and the ability of multiple clades and sub-clades of RSV to co-circulate are likely mechanisms contributing to the evasion of herd immunity. Surveillance and large-scale whole-genome sequencing of RSV is currently limited but would help identify its evolutionary dynamics and sites of selective immune evasion. In this study, we performed complete-genome next-generation sequencing of 92 RSV isolates from infants in central Tennessee during the 2012–2014 RSV seasons. We identified multiple co-circulating clades of RSV from both the A and B groups. Each clade is defined by signature N- and O-linked glycosylation patterns. Analyses of specific RSV genes revealed high rates of positive selection in the attachment (G) gene. We identified RSV-A viruses in circulation with and without a recently reported 72-nucleotide G gene sequence duplication. Furthermore, we show evidence of convergent evolution of G gene sequence duplication and fixation over time, which suggests a potential fitness advantage of RSV with the G sequence duplication.
引用
收藏
相关论文
共 82 条
[1]  
Collins PL(2013)Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease Current topics in microbiology and immunology 372 38-549
[2]  
Fearns R(1956)Recovery of cytopathogenic agent from chimpanzees with coryza Proc Soc Exp Biol Med 92 544-5434
[3]  
Graham BS(1991)Genetic diversity of the attachment protein of subgroup B respiratory syncytial viruses Journal of virology 65 5425-316
[4]  
Blount RE(2005)Intragroup antigenic diversity of human respiratory syncytial virus (group A) isolated in Argentina and Chile Journal of medical virology 77 311-8226
[5]  
Morris JA(2013)The comparative genomics of human respiratory syncytial virus subgroups A and B: genetic variability and molecular evolutionary dynamics Journal of virology 87 8213-57
[6]  
Savage RE(2013)Clinical and epidemiologic features of respiratory syncytial virus Current topics in microbiology and immunology 372 39-1555
[7]  
Sullender WM(2010)Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis Lancet 375 1545-3454
[8]  
Mufson MA(2015)Local evolutionary patterns of human respiratory syncytial virus derived from whole-genome sequencing Journal of virology 89 3444-3968
[9]  
Anderson LJ(2014)Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Children: A Real-World Perspective International journal of pediatrics 2014 571609-567
[10]  
Wertz GW(2005) selection of respiratory syncytial viruses resistant to palivizumab Journal of virology 79 3962-377